As of January 22, 2025, Scilex Holding (SCLX) has a market cap of $80.627 million USD. According to our data, Scilex Holding is ranked No.7850 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $80.63 M |
18.09%
|
Dec 31, 2024 | $68.28 M |
-79.12%
|
Dec 29, 2023 | $0.33 B |
-48.87%
|
Dec 30, 2022 | $0.64 B |
-60.26%
|
Dec 31, 2021 | $1.61 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
Assertio Therapeutics
ASRT
|
$77.34 M |
-0.000 M
|
USA
|
Pacira Biosciences
PCRX
|
$1.04 B |
-0.000 M
|
USA
|
Collegium Pharmaceutical
COLL
|
$1.05 B |
0.000 M
|
USA
|
Amneal Pharmaceuticals
AMRX
|
$3.94 B |
1.296 B
|
USA
|
Viatris
VTRS
|
$13.30 B |
-0.000 M
|
USA
|
Perrigo
PRGO
|
$3.28 B |
0.000 M
|
Ireland
|
Bausch Health
BHC
|
$2.85 B |
6.423 M
|
Canada
|
Jazz Pharmaceuticals
JAZZ
|
$7.31 B |
0.000 M
|
Ireland
|
Indivior PLC
INDV
|
$1.50 B |
0.000 M
|
USA
|
Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
Supernus Pharmaceuticals
SUPN
|
$2.11 B |
-0.000 M
|
USA
|
Market Cap | = | SCLX Stock Price | * | SCLX Shares Outstanding |
= | $0.44 | * | 0.18 B | |
= | $80.63 M |